When analyzing the expression of GPM6A mRNA in cancer using The Cancer Genome Atlas (TCGA) dataset, it was found that downregulation of GPM6A enhanced the migration, proliferation, and EMT of lung adenocarcinoma cells, whereas upregulation of GPM6A inhibited their development [17]. The gene discussed is GPM6A; the disease is lung adenocarcinoma.